These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6142250)

  • 21. [Clinical trials of cholesterol lowering for the secondary prevention of coronary heart disease].
    Koizumi J
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():252-6. PubMed ID: 17821900
    [No Abstract]   [Full Text] [Related]  

  • 22. Treating average cholesterol levels in patients with coronary heart disease.
    Lindbloom EJ
    J Fam Pract; 1999 Feb; 48(2):94-5. PubMed ID: 10037537
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial on CHD.
    Riesen WF
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S1-2. PubMed ID: 9044998
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of blood cholesterol in atherosclerosis and coronary heart disease.
    Sherwin R; Lewis C; Russell RP
    Md Med J; 1986 Apr; 35(4):248-50. PubMed ID: 3713460
    [No Abstract]   [Full Text] [Related]  

  • 25. Aggressive lipid-lowering therapy: a clinical imperative.
    Pedersen TR
    Eur Heart J; 1998 Oct; 19 Suppl M():M15-21. PubMed ID: 9821012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low cholesterol and increased risk.
    Lancet; 1989 Jun; 1(8652):1423-5. PubMed ID: 2567432
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease].
    Jost S; Lichtlen PR
    Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.
    Simes J; Furberg CD; Braunwald E; Davis BR; Ford I; Tonkin A; Shepherd J
    Eur Heart J; 2002 Feb; 23(3):207-15. PubMed ID: 11792135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives.
    McKenna CJ; Sugrue DD
    Ir Med J; 1995; 88(6):191. PubMed ID: 8575912
    [No Abstract]   [Full Text] [Related]  

  • 30. Lowering cholesterol levels in patients with coronary heart disease. The LIPID Study Management Committee.
    Med J Aust; 1995 May; 162(9):455-6. PubMed ID: 7746199
    [No Abstract]   [Full Text] [Related]  

  • 31. Lowering blood cholesterol to prevent heart disease. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1985; 5(7):27. PubMed ID: 3887139
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of coronary heart disease by cholesterol lowering diet.
    Miettinen M
    Postgrad Med J; 1975; 51(8):47-51. PubMed ID: 768947
    [No Abstract]   [Full Text] [Related]  

  • 33. Ischemic heart disease and lipids in blood and diet.
    Stallones RA
    Annu Rev Nutr; 1983; 3():155-85. PubMed ID: 6357234
    [No Abstract]   [Full Text] [Related]  

  • 34. Total serum cholesterol and ischemic heart disease risk in clinical trials and observational studies.
    Tyroler HA
    Am J Prev Med; 1985; 1(4):18-24. PubMed ID: 3916714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of cholelithiasis in men and women ingesting a serum-cholesterol-lowering diet.
    Miettinen M; Turpeinen O; Karvonen MJ; Paavilainen E; Elosuo R
    Ann Clin Res; 1976 Apr; 8(2):111-6. PubMed ID: 779589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid lowering in post-MI patients with normal cholesterol.
    Lawless C; Force R
    J Fam Pract; 1997 Jan; 44(1):30. PubMed ID: 9010366
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.
    Johannesson M; Jönsson B; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
    N Engl J Med; 1997 Jan; 336(5):332-6. PubMed ID: 9011785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications of clinical studies: can we compare different subgroups defined a posteriori?
    Vohnout B
    Eur Heart J; 2001 May; 22(9):798. PubMed ID: 11350113
    [No Abstract]   [Full Text] [Related]  

  • 39. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum cholesterol and death from coronary heart disease.
    Olson RE
    JAMA; 1987 May 22-29; 257(20):2755-6. PubMed ID: 3573266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.